Second- and third-line chemotherapy in patients with metastatic pancreatic adenocarcinoma: Feasibility and potential benefits in a retrospective series of 117 patients-Reference-Cited by-同舟云学术

Second- and third-line chemotherapy in patients with metastatic pancreatic adenocarcinoma: Feasibility and potential benefits in a retrospective series of 117 patients

Published:2009-10 Issue:10-11 Volume:33 Page:1036-1044
ISSN:0399-8320
Container-title:Gastroentérologie Clinique et Biologique
language:en
Short-container-title:Gastroentérologie Clinique et Biologique

Author:

Bachet J.-B.,Mitry E.,Lièvre A.,Lepère C.,Vaillant J.-N.,Declety G.,Parlier H.,Emile J.-F.,Julié C.,Rougier P.

Publisher

Elsevier BV

Subject

Gastroenterology,General Medicine

Reference46 articles.

1. EUROCARE-3 summary: cancer survival in Europe at the end of the 20th century;Coleman;Ann Oncol,2003

2. Does anyone survive pancreatic ductal adenocarcinoma? A nationwide study re-evaluating the data of the Finnish Cancer Registry;Carpelan-Holmstrom;Gut,2005

3. Incidence of gastrointestinal cancers in France;Bouvier;Gastroenterol Clin Biol,2004

4. Chemotherapy improves survival and quality of life in advanced pancreatic and biliary cancer;Glimelius;Ann Oncol,1996

5. Gemcitabine in combination with oxaliplatin compared with gemcitabine alone in locally advanced or metastatic pancreatic cancer: results of a GERCOR and GISCAD phase III trial;Louvet;J Clin Oncol,2005

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and safety of different chemotherapy regimens in patients with disseminated pancreatic cancer over 65 years old;Surgery and Oncology;2024-06-07

2. Clinical practice guidelines for interventional treatment of pancreatic cancer;Recent Advances in Nanocarriers for Pancreatic Cancer Therapy;2024

3. KRAS G12C inhibitors: also a new promising new targeted therapy in advanced pancreatic adenocarcinoma?;Translational Cancer Research;2023-12

4. Systemic therapy for metastatic pancreatic cancer;Malignant tumours;2023-10-09

5. A Prospective Feasibility Trial to Challenge Patient–Derived Pancreatic Cancer Organoids in Predicting Treatment Response;Cancers;2021-05-21